Does INTERFERON BETA-1B Cause Injection site discolouration? 111 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 111 reports of Injection site discolouration have been filed in association with INTERFERON BETA-1B (Betaseron). This represents 0.9% of all adverse event reports for INTERFERON BETA-1B.
111
Reports of Injection site discolouration with INTERFERON BETA-1B
0.9%
of all INTERFERON BETA-1B reports
0
Deaths
14
Hospitalizations
How Dangerous Is Injection site discolouration From INTERFERON BETA-1B?
Of the 111 reports, 14 (12.6%) required hospitalization.
Is Injection site discolouration Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for INTERFERON BETA-1B. However, 111 reports have been filed with the FAERS database.
What Other Side Effects Does INTERFERON BETA-1B Cause?
Multiple sclerosis relapse (1,229)
Influenza like illness (1,042)
Injection site pain (1,014)
Fatigue (783)
Drug ineffective (767)
Injection site erythema (724)
Injection site reaction (707)
Pain (597)
Headache (596)
Multiple sclerosis (589)
What Other Drugs Cause Injection site discolouration?
ETANERCEPT (1,846)
DUPILUMAB (779)
CERTOLIZUMAB PEGOL (597)
ADALIMUMAB (554)
EVOLOCUMAB (476)
GLATIRAMER (270)
EXENATIDE (266)
TERIPARATIDE (249)
ASFOTASE ALFA (243)
ENBREL (231)
Which INTERFERON BETA-1B Alternatives Have Lower Injection site discolouration Risk?
INTERFERON BETA-1B vs INTERFERON GAMMA
INTERFERON BETA-1B vs INTERFERON GAMMA-1B
INTERFERON BETA-1B vs INVEGA
INTERFERON BETA-1B vs INVEGA SUSTENNA
INTERFERON BETA-1B vs INVESTIGATIONAL BIOSIMILARS